New Biosimilar Under Review in Top Specialty Pharmacy News

Catch up with any news you missed this week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/new-biosimilar-under-review-in-top-specialty-pharm" target="_blank">View the story "New Biosimilar Under Review in Top Specialty Pharmacy News" on Storify</a>]

Related Content:

Specialty Pharmacy
Establishing Workflow for In-clinic, Home Administration of Cabotegravir-rilpivirine Injections for HIV-1
Updates in Prevention, Treatment of Cytokine Release Syndrome, Neurologic Toxicities for Patients With Multiple Myeloma
Study: Ibrutinib Effective Treatment for Difficult to Treat Forms of Hairy Cell Leukemia